Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 293

1.
2.

Improvements in access to malaria treatment in Tanzania following community, retail sector and health facility interventions -- a user perspective.

Alba S, Dillip A, Hetzel MW, Mayumana I, Mshana C, Makemba A, Alexander M, Obrist B, Schulze A, Kessy F, Mshinda H, Lengeler C.

Malar J. 2010 Jun 15;9:163. doi: 10.1186/1475-2875-9-163.

3.
4.

Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania.

Sabot OJ, Mwita A, Cohen JM, Ipuge Y, Gordon M, Bishop D, Odhiambo M, Ward L, Goodman C.

PLoS One. 2009 Sep 2;4(9):e6857. doi: 10.1371/journal.pone.0006857.

5.

Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.

Smith N, Obala A, Simiyu C, Menya D, Khwa-Otsyula B, O'Meara WP.

Malar J. 2011 Oct 26;10:316. doi: 10.1186/1475-2875-10-316.

6.

Diffusion of subsidized ACTs in accredited drug shops in Tanzania: determinants of stocking and characteristics of early and late adopters.

Larson PS, Yadav P, Alphs S, Arkedis J, Massaga J, Sabot O, Cohen JL.

BMC Health Serv Res. 2013 Dec 18;13:526. doi: 10.1186/1472-6963-13-526.

7.
8.

Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT).

Ringsted FM, Massawe IS, Lemnge MM, Bygbjerg IC.

Malar J. 2011 Aug 15;10:238. doi: 10.1186/1475-2875-10-238.

9.

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.

O'Connell KA, Gatakaa H, Poyer S, Njogu J, Evance I, Munroe E, Solomon T, Goodman C, Hanson K, Zinsou C, Akulayi L, Raharinjatovo J, Arogundade E, Buyungo P, Mpasela F, Adjibabi CB, Agbango JA, Ramarosandratana BF, Coker B, Rubahika D, Hamainza B, Chapman S, Shewchuk T, Chavasse D.

Malar J. 2011 Oct 31;10:326. doi: 10.1186/1475-2875-10-326.

10.

The challenge to avoid anti-malarial medicine stock-outs in an era of funding partners: the case of Tanzania.

Mikkelsen-Lopez I, Shango W, Barrington J, Ziegler R, Smith T, deSavigny D.

Malar J. 2014 May 11;13:181. doi: 10.1186/1475-2875-13-181.

11.

A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops.

Cohen JM, Sabot O, Sabot K, Gordon M, Gross I, Bishop D, Odhiambo M, Ipuge Y, Ward L, Mwita A, Goodman C.

BMC Health Serv Res. 2010 Jul 2;10 Suppl 1:S6. doi: 10.1186/1472-6963-10-S1-S6.

12.

Cluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherence.

Bruxvoort K, Festo C, Kalolella A, Cairns M, Lyaruu P, Kenani M, Kachur SP, Goodman C, Schellenberg D.

Am J Trop Med Hyg. 2014 Oct;91(4):844-53. doi: 10.4269/ajtmh.14-0126.

13.

Malaria treatment in the retail sector: knowledge and practices of drug sellers in rural Tanzania.

Hetzel MW, Dillip A, Lengeler C, Obrist B, Msechu JJ, Makemba AM, Mshana C, Schulze A, Mshinda H.

BMC Public Health. 2008 May 9;8:157. doi: 10.1186/1471-2458-8-157.

14.
15.

SMS for Life: a pilot project to improve anti-malarial drug supply management in rural Tanzania using standard technology.

Barrington J, Wereko-Brobby O, Ward P, Mwafongo W, Kungulwe S.

Malar J. 2010 Oct 27;9:298. doi: 10.1186/1475-2875-9-298.

16.

Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.

Goodman C, Kachur SP, Abdulla S, Mwageni E, Nyoni J, Schellenberg JA, Mills A, Bloland P.

Trop Med Int Health. 2004 Jun;9(6):655-63.

17.

Awareness of anti-malarial policy and malaria treatment practices of patent medicine vendors in three Nigerian states.

Oladepo O, Brieger W, Adeoye B, Lawal B, Peters DH.

Afr J Med Med Sci. 2011 Dec;40(4):345-52.

PMID:
22783684
18.

Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania.

Yadav P, Cohen JL, Alphs S, Arkedis J, Larson PS, Massaga J, Sabot O.

Malar J. 2012 Aug 28;11:299. doi: 10.1186/1475-2875-11-299.

19.

The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.

Kangwana BP, Kedenge SV, Noor AM, Alegana VA, Nyandigisi AJ, Pandit J, Fegan GW, Todd JE, Brooker S, Snow RW, Goodman CA.

PLoS Med. 2011 May;8(5):e1000437. doi: 10.1371/journal.pmed.1000437.

20.
Items per page

Supplemental Content

Support Center